Conversion therapy for advanced intrahepatic cholangiocarcinoma with lenvatinib and pembrolizumab combined with gemcitabine plus cisplatin: A case report and literature review

BACKGROUND: Intrahepatic cholangiocarcinoma (ICC) is a highly malignant biliary tumor. Patients with unresectable and advanced ICC have a poor prognosis with current gemcitabine-based chemotherapy. Combination therapy strategies based on immunotherapy have achieved promising results in various tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wei, Luo, Chu, Zhang, Zun-Yi, Zhang, Bi-Xiang, Chen, Xiao-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868150/
https://www.ncbi.nlm.nih.gov/pubmed/36700218
http://dx.doi.org/10.3389/fimmu.2022.1079342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868150/
https://www.ncbi.nlm.nih.gov/pubmed/36700218
http://dx.doi.org/10.3389/fimmu.2022.1079342

Ejemplares similares